中國外運(00598.HK)與招商創新基金及招商創投就設立基金訂立合夥協議
格隆匯6月11日丨中國外運(00598.HK)發佈公吿,2021年6月11日,公司與招商創新基金及招商創投就設立基金訂立合夥協議,據此,基金的認繳出資總額為人民幣3.001億元,其中,招商創新基金(作為有限合夥人)、公司(作為有限合夥人)及招商創投(作為普通合夥人)應以現金方式分別認繳出資人民幣1.5億元、人民幣1.5億元及人民幣10萬元。基金將不會被視為公司附屬公司,及其財務業績亦不會合併到公司賬目中。參與設立該基金可作為公司的補充投資渠道,亦將帶來更多潛在的物流創新投資目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.